Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cirmtuzumab Consolidation in CLL on Venetoclax
NCT04501939Phase 2Active, not recruiting
- Sponsor
- University of California, San Diego
- Start
- Aug 2020
- Primary completion
- Jul 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cirmtuzumab in chronic lymphocytic leukemia (CLL), sponsored by University of California, San Diego. Started Aug 2020; status: active, not recruiting.
02
Drugs
cirmtuzumab
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT04501939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04501939.